Drug Shortage Report for KIDROLASE

Last updated on 2025-04-23 History
Report ID 101429
Drug Identification Number 01926438
Brand name KIDROLASE
Common or Proper name L-asparaginase
Company Name JAZZ PHARMACEUTICALS FRANCE SAS
Market Status CANCELLED POST MARKET
Active Ingredient(s) ASPARAGINASE
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 vial / pack
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-12-16
Estimated end date Unknown
Actual end date 2021-07-07
Shortage status Resolved
Updated date 2025-04-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 84 QUAI CHARLES DE GAULLE CITY ONE
LYON, AUVERGNE-RHONE-ALPES
FRANCE 69006
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-04-23 French Compare
v11 2025-04-23 English Compare
v10 2020-01-10 French Compare
v9 2020-01-10 English Compare
v8 2019-12-24 French Compare
v7 2019-12-24 English Compare
v6 2019-12-24 English Compare
v5 2019-12-17 English Compare
v4 2019-12-16 French Compare
v3 2019-12-16 English Compare
v2 2019-12-16 English Compare
v1 2019-12-16 English Compare

Showing 1 to 12 of 12